This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignees: Cha University Industry-Academic Cooperation Foundation, Ewha University-Industry Collaboration Foundation, Yonsei University. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2025
Title: The Innovative Contributions of Jihyeon Jeong
Introduction
Jihyeon Jeong is a notable inventor based in Seoul, South Korea. He has made significant strides in the field of cancer research through his innovative patent. His work focuses on developing compositions that can prevent, ameliorate, or treat cancer effectively.
Latest Patents
Jihyeon Jeong holds a patent for a composition aimed at the prevention, amelioration, or treatment of cancer. The patent describes alpha-beta unsaturated aryl, heteroaryl, and cycloalkylene ketone compounds that are effective in inhibiting the growth of cancer cells. This composition not only targets cancer cells but also inhibits their metastasis to other tissues, showcasing its potential in cancer therapy. He has 1 patent to his name.
Career Highlights
Throughout his career, Jihyeon Jeong has been associated with prominent institutions. He has worked with the Ewha University-Industry Collaboration Foundation and the Cha University Industry-Academic Cooperation Foundation. His contributions to these organizations have been instrumental in advancing research and innovation in cancer treatment.
Collaborations
Jihyeon Jeong has collaborated with several professionals in his field, including Youngjoo Kwon and Soo-Yeon Hwang. Their combined efforts have contributed to the development of effective cancer treatment strategies.
Conclusion
Jihyeon Jeong's innovative work in cancer research highlights the importance of collaboration and creativity in the scientific community. His contributions are paving the way for new treatment options that could significantly impact cancer therapy.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile